Timothy Rolph, Chief Scientific Officer: Akero Therapeutics AKRO Sell · Filed 23/06/21

Trade details

Type: Insider sale
Amount: $2,692,158.5
Shares · price: 49,325 sh · $54.58 a share
Held after: 180,095 sh
Stock: Akero Therapeutics AKRO
Person: Timothy RolphChief Scientific Officer
Trade date: 23/06/16
Filed: 23/06/21
Days to filing: 5 days

Sold 21.5% of holdings

Share of holding sold: 21.5%

Akero Therapeutics trades, last 26 weeks

What else happened in Akero Therapeutics around then

Filed or reported within 30 days of the trade day · 23/05/17~23/07/16

Timothy Rolph's recent trades

Timothy RolphChief Scientific Officer
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$527.4K
11,463 sh
$527.4K
Filed 25/10/09
Traded 25/10/07
Timothy RolphChief Scientific Officer
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$48.6K
1,037 sh
$48.6K
Filed 25/10/09
Traded 25/10/07
Timothy RolphChief Scientific Officer
SellAkero Therapeutics
Sell
Akero Therapeutics
AKRO
$23.8K
553 sh
$23.8K
Filed 25/09/12
Traded 25/09/11
Timothy RolphChief Scientific Officer
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$550.6K
12,466 sh
$550.6K
Filed 25/09/10
Traded 25/09/08
Timothy RolphChief Scientific Officer
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$1,526
34 sh
$1,526
Filed 25/09/10
Traded 25/09/08